A novel class of advanced glycation inhibitors ameliorates renal and cardiovascular damage in experimental rat models - Concepedia

Concepedia

Publication | Open Access

A novel class of advanced glycation inhibitors ameliorates renal and cardiovascular damage in experimental rat models

DOI Full Paper Access

48

Citations

25

References

2007

Year

Y. Izuhara, Masaomi Nangaku, Shunya Takizawa, Shosuke Takahashi, Jing Shao, H Oishi, Hiroyuki Kobayashi, C. van Ypersele de Strihou, T Miyata

Nephrology Dialysis Transplantation

Abstract

TM2002 is a novel, non-toxic AGE inhibitor acting through ARB-like mechanisms, able to prevent renal and cardiovascular diseases independently of blood pressure lowering.

References

	Year	Citations

Page 1